GAINESVILLE— September 24, 2020— Rescue Hearing Inc (RHI), a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the addition of Drug Development Advisor Dr. Lee Golden.
“Lee is a seasoned physician, scientist, and drug development professional,” said RHI CEO Jim Ayala. “He has industry experience in all phases of drug development including; proof of concept, preclinical safety/toxicology, human clinical trial execution, regulatory filings, and commercialization. Lee also has extensive business experience in negotiating agreements with institutional investors (VC, Private equity), large pharma (public and private), third-party vendors, CROs, and academic research institutions. Lee fits in well with the RHI culture of creating commercial therapies to improve the quality of life for patients with hearing loss.”
Lee Golden, M.D., joins RHI with more than 19 years in the Pharmaceutical and Biotech industries. He is currently the Head of Global Clinical Development at PTC Therapeutics, Inc and Chairman of the Board at Coagulation Science LLC. Dr. Golden first began his career at Pfizer Pharmaceuticals as a Medical Director. He then served in various senior leadership positions at Novartis Pharmaceuticals Corp., Elan Pharmaceuticals Inc., and Actelion Pharmaceuticals US, Inc. He also worked as Global Head of Cardiovascular and Hematology at Eisai Inc., where he led global research and development from discovery through approval. In 2011, Dr. Golden became Senior Vice President and Therapeutic Area Head at Mesoblast Inc. In 2016, he became Chief Medical Officer for Gemphire Therapeutics and was CMO at Espero BioPharma just prior to his current role. Dr. Golden received his M.D. from the New York University School of Medicine and his B.S. from the University of Michigan.
“I am very excited to join as an advisor to RHI and help them bring important new therapies to patients suffering with hearing loss” said Lee Golden, MD. “RHI has an exciting group of potential therapies and a world class group of scientists.”
Dr. Golden will be advising on the development of RHI’s gene therapy pipeline and investor relations.
About Rescue Hearing Inc.
Rescue Hearing Inc. has assembled a team of the top physicians and researchers in the hearing loss field to develop cutting-edge gene therapies and diagnostics to improve the quality of life for patients with debilitating hearing loss.